Development Level

Tbio 29 | 10,625
Tchem 7 | 1,890
Tdark 3 | 7,003

IMPC Term

preweaning lethality, complete... 2 | 633
abnormal retinal pigmentation 1 | 61
decreased body weight 1 | 174
decreased circulating aspartat... 1 | 27
decreased circulating serum al... 1 | 79
decreased fasted circulating g... 1 | 49
decreased grip strength 1 | 123
enlarged spleen 1 | 26
increased circulating serum al... 1 | 25
increased mean corpuscular hem... 1 | 93
increased or absent threshold ... 1 | 128

Disease

osteosarcoma 16 | 7,933
ovarian cancer 14 | 8,484
Cancer 11 | 2,346
medulloblastoma, large-cell 10 | 6,234
psoriasis 8 | 6,685
glioblastoma 7 | 5,572
lung cancer 7 | 4,466
Anemia 6 | 252
adult high grade glioma 6 | 2,148
atypical teratoid / rhabdoid tumor 6 | 4,369
subependymal giant cell astrocytoma 6 | 2,287
Hepatitis 5 | 61
Hepatitis C 5 | 90
Renal Cell Carcinoma 5 | 199
astrocytic glioma 5 | 2,241
tuberculosis 5 | 1,557
Diarrhea 4 | 155
Hepatitis B 4 | 103
Vici syndrome 4 | 16
Weight decreased 4 | 18
intraductal papillary-mucinous neoplasm (IPMN) 4 | 3,289
Breast cancer 3 | 3,094
Carcinoma 3 | 2,147
Drug-Induced Liver Injury 3 | 118
Gastrointestinal stromal tumor 3 | 61
Hypersensitivity reaction type II disease 3 | 235
Impaired glucose tolerance 3 | 12
Influenza 3 | 142
Insulin Resistance 3 | 48
Kidney disease 3 | 396
Leukopenia 3 | 42
Malaria 3 | 140
Melanoma 3 | 261
Necrosis 3 | 51
Pancreatic Neuroendocrine Tumor 3 | 45
Renal Insufficiency 3 | 10
Rheumatoid Arthritis 3 | 1,160
ependymoma 3 | 2,514
gastric cancer 3 | 430
hepatocellular carcinoma 3 | 532
juvenile dermatomyositis 3 | 1,189
lung adenocarcinoma 3 | 2,713
malignant mesothelioma 3 | 3,162
medulloblastoma 3 | 1,524
oligodendroglioma 3 | 2,849
pancreatic cancer 3 | 2,300
pancreatic carcinoma 3 | 567
posterior fossa group B ependymoma 3 | 1,530
spina bifida 3 | 1,064
Acquired immunodeficiency syndrome 2 | 164
Acute kidney injury 2 | 65
Adult T-Cell Lymphoma/Leukemia 2 | 30
Allergic hypersensitivity disease 2 | 123
Arthritis 2 | 248
Atherosclerosis 2 | 275
Autistic Disorder 2 | 320
Cardiac arrest 2 | 26
Centronuclear myopathy 2 | 21
Colonic Neoplasms 2 | 126
Connective tissue disease 2 | 59
Coronary artery disease 2 | 240
Crohn Disease 2 | 97
Cryoglobulinemia 2 | 15
Diabetes Mellitus, Insulin-Dependent 2 | 76
Encephalitis 2 | 54
Fatty Liver 2 | 48
Heart disease 2 | 279
Heart failure 2 | 80
Hypertriglyceridemia 2 | 18
Hypotension 2 | 53
Hypothyroidism 2 | 89
Inflammatory bowel disease 2 | 142
Liver Cirrhosis 2 | 101
Liver Cirrhosis, Experimental 2 | 108
Liver disease 2 | 219
Lung Neoplasms 2 | 171
Lung disease 2 | 132
Multiple Sclerosis 2 | 498
Multiple myeloma 2 | 1,327
Myocardial Infarction 2 | 126
Neural Tube Defects 2 | 27
Neurodegenerative disease 2 | 383
Neuropathy 2 | 210
Pancreatic Neoplasm 2 | 79
Parkinson's disease 2 | 364
Polycythemia Vera 2 | 24
Sepsis 2 | 21
Stevens-Johnson syndrome 2 | 78
Thrombocytopenia 2 | 105
Thyrotoxicosis 2 | 38
Vasculitis 2 | 64
acute myeloid leukemia 2 | 780
breast carcinoma 2 | 1,614
colon cancer 2 | 1,475
diabetes mellitus 2 | 1,663
intraductal papillary-mucinous adenoma (IPMA) 2 | 2,956
intraductal papillary-mucinous carcinoma (IPMC) 2 | 2,988
pilocytic astrocytoma 2 | 3,086
pituitary cancer 2 | 1,972
progressive supranuclear palsy 2 | 674

Tissue

Nervous System 39 | 18,561
Female tissues 38 | 18,647
Digestive Tract 37 | 18,473
Urinary Tract 37 | 18,444
Skin and soft tissues 36 | 18,115
Endocrine System 33 | 18,512
Blood and immune system 32 | 17,995
Cardiovascular System 31 | 17,958
Liver and Pancreas 31 | 18,136
Respiratory system 28 | 17,484
Male tissues 27 | 17,969

Target Family

Non-IDG 28 | 11,971
Kinase 7 | 634
Enzyme 4 | 4,146

KEGG Pathway

Autophagy 39 | 39
Metabolic pathways 1,254 | 1,254
Olfactory transduction 412 | 412
Pathways in cancer 402 | 402
HTLV-I infection 339 | 339
PI3K-Akt signaling pathway 338 | 338
Endocytosis 326 | 326
Epstein-Barr virus infection 279 | 279
Neuroactive ligand-receptor in... 276 | 276
Cytokine-cytokine receptor int... 262 | 262
Herpes simplex infection 262 | 262
MAPK signaling pathway 255 | 255
Viral carcinogenesis 253 | 253
Phagosome 231 | 231
Cell adhesion molecules (CAMs) 225 | 225
Ras signaling pathway 225 | 225
Rap1 signaling pathway 213 | 213
Regulation of actin cytoskelet... 213 | 213
Proteoglycans in cancer 202 | 202
cAMP signaling pathway 201 | 201
Focal adhesion 200 | 200
Natural killer cell mediated c... 199 | 199
Huntington's disease 194 | 194
Tuberculosis 187 | 187
Influenza A 184 | 184
Chemokine signaling pathway 182 | 182
Calcium signaling pathway 181 | 181
Axon guidance 176 | 176
Purine metabolism 171 | 171
Alzheimer's disease 169 | 169
Tight junction 169 | 169
NOD-like receptor signaling pa... 168 | 168
Protein processing in endoplas... 165 | 165
Transcriptional misregulation ... 165 | 165
cGMP-PKG signaling pathway 165 | 165
RNA transport 164 | 164
Oxytocin signaling pathway 158 | 158
Jak-STAT signaling pathway 157 | 157
Antigen processing and present... 156 | 156
Hippo signaling pathway 154 | 154
mTOR signaling pathway 153 | 153
Non-alcoholic fatty liver dise... 151 | 151
Adrenergic signaling in cardio... 150 | 150
MicroRNAs in cancer 150 | 150
Breast cancer 146 | 146
Alcoholism 145 | 145
Hepatitis B 145 | 145
Phospholipase D signaling path... 145 | 145
Parkinson's disease 142 | 142
Wnt signaling pathway 142 | 142
Signaling pathways regulating ... 141 | 141
Apoptosis 140 | 140
Insulin signaling pathway 138 | 138
Ubiquitin mediated proteolysis 137 | 137
Viral myocarditis 137 | 137
Measles 135 | 135
Ribosome 134 | 134
Oxidative phosphorylation 133 | 133
FoxO signaling pathway 132 | 132
Hepatitis C 132 | 132
Spliceosome 132 | 132
Dopaminergic synapse 131 | 131
Osteoclast differentiation 131 | 131
Autoimmune thyroid disease 130 | 130
Toxoplasmosis 130 | 130
Cell cycle 125 | 125
Platelet activation 124 | 124
AMPK signaling pathway 123 | 123
Lysosome 123 | 123
Type I diabetes mellitus 122 | 122
Vascular smooth muscle contrac... 121 | 121
Graft-versus-host disease 120 | 120
Sphingolipid signaling pathway 120 | 120
Neurotrophin signaling pathway 119 | 119
Oocyte meiosis 119 | 119
Th17 cell differentiation 119 | 119
Thyroid hormone signaling path... 118 | 118
Allograft rejection 116 | 116
Glutamatergic synapse 116 | 116
Leukocyte transendothelial mig... 116 | 116
Carbon metabolism 114 | 114
Serotonergic synapse 114 | 114
Cholinergic synapse 110 | 110
TNF signaling pathway 110 | 110
Insulin resistance 109 | 109
Hematopoietic cell lineage 108 | 108
Systemic lupus erythematosus 108 | 108
Chagas disease (American trypa... 106 | 106
T cell receptor signaling path... 104 | 104
Th1 and Th2 cell differentiati... 104 | 104
Glucagon signaling pathway 103 | 103
HIF-1 signaling pathway 103 | 103
Toll-like receptor signaling p... 103 | 103
Melanogenesis 102 | 102
Pyrimidine metabolism 102 | 102
AGE-RAGE signaling pathway in ... 101 | 101
Endocrine resistance 101 | 101
Estrogen signaling pathway 101 | 101
Retrograde endocannabinoid sig... 101 | 101
Amoebiasis 100 | 100
Rheumatoid arthritis 100 | 100

This is where graphics are reside..
Name Gene Development Level Target Family Log Novelty  Pubmed Score  Antibody Count  Knowledge Availability 
Insulin INS Tbio Non-IDG -5.14691 141255.4 1549
Cysteine protease ATG4A ATG4A Tbio Enzyme -0.98696 7.89 199
Serine/threonine-protein kinase ULK2 ULK2 Tchem Kinase -1.07146 10.6 355
Ubiquitin-like-conjugating enzyme ATG10 ATG10 Tbio Non-IDG -1.17565 13.8 187
Gamma-aminobutyric acid receptor-associated protein-like 1 GABARAPL1 Tbio Non-IDG -2.29988 198.3 134
Autophagy-related protein 13 ATG13 Tbio Non-IDG -1.41149 24.1 305
Phosphatidylinositol 3-kinase catalytic subunit type 3 PIK3C3 Tchem Kinase -2.26683 181.8 641
Interferon gamma IFNG Tbio Non-IDG -3.87939 5432.4 1711
Interferon alpha-7 IFNA7 Tdark Non-IDG -0.67991 3.90 46
Interferon alpha-10 IFNA10 Tbio Non-IDG -1.24816 16.2 115